| scholarly article | Q13442814 |
| P50 | author | Philippe Menei | Q56561669 |
| P2093 | author name string | Catherine Passirani | |
| Anne Clavreul | |||
| Marie-Claire Venier-Julienne | |||
| Mathilde Roger | |||
| Laurence Sindji | |||
| Paul Schiller | |||
| Claudia Montero-Menei | |||
| P433 | issue | 32 | |
| P921 | main subject | nanoparticle | Q61231 |
| mesenchymal stem cell | Q1922379 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 8393-8401 | |
| P577 | publication date | 2010-08-05 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors | |
| P478 | volume | 31 |
| Q90207123 | A Review of Controlled Drug Delivery Systems Based on Cells and Cell Membranes |
| Q39117236 | A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles |
| Q36776738 | A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer |
| Q37413328 | A review of stem cell translation and potential confounds by cancer stem cells. |
| Q38227489 | Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy |
| Q60895177 | Analysis of nanoparticle delivery to tumours |
| Q41634176 | Bacterial membrane vesicles as novel nanosystems for drug delivery |
| Q37896455 | Bio-inspired, bioengineered and biomimetic drug delivery carriers |
| Q57428689 | Bioresponsive materials |
| Q28067855 | Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking |
| Q39005226 | Cancer nanomedicine: progress, challenges and opportunities |
| Q26830028 | Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers |
| Q28385606 | Cell delivery of therapeutic nanoparticles |
| Q39031369 | Cell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds |
| Q38226664 | Cells as delivery vehicles for cancer therapeutics |
| Q37056276 | Concise review: mesenchymal stem cells and translational medicine: emerging issues. |
| Q28552160 | Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment |
| Q28386699 | Convergence of nanotechnology and cancer prevention: are we there yet? |
| Q28547179 | Design strategies and applications of circulating cell-mediated drug delivery systems |
| Q37845396 | Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis |
| Q30413487 | Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma |
| Q42391294 | Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse |
| Q38378499 | Engineering Stem Cells for Biomedical Applications. |
| Q27026414 | Engineering mesenchymal stem cells for regenerative medicine and drug delivery |
| Q37707194 | Formulation and Drug Loading Features of Nano-Erythrocytes. |
| Q38133556 | From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? |
| Q38001430 | Functionalized nanostructures with application in regenerative medicine |
| Q67201058 | Gene editing for immune cell therapies |
| Q55461236 | Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. |
| Q39164984 | Gold nanoparticle-loaded neural stem cells for photothermal ablation of cancer. |
| Q45338034 | Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia |
| Q50025868 | Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410. |
| Q47830442 | Inhibitory effect and molecular mechanism of mesenchymal stem cells on NSCLC cells |
| Q36082516 | Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. |
| Q39245263 | Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells |
| Q48891673 | Isolation of a new cell population in the glioblastoma microenvironment. |
| Q92723425 | Long-Term Impact of Zinc Oxide Nanoparticles on Differentiation and Cytokine Secretion of Human Adipose-Derived Stromal Cells |
| Q59131876 | MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma |
| Q38817890 | Malignant transformation of bone marrow stromal cells induced by the brain glioma niche in rats |
| Q90168903 | Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration |
| Q36511906 | Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q37729093 | Mesenchymal stem cells: a new trend for cell therapy |
| Q89842625 | Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model |
| Q38786696 | Mitomycin C-treated human-induced pluripotent stem cells as a safe delivery system of gold nanorods for targeted photothermal therapy of gastric cancer |
| Q26827999 | Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency |
| Q88204108 | Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting |
| Q94525605 | Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review |
| Q91857312 | Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders |
| Q57377122 | Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery |
| Q36224493 | New therapeutic approaches for malignant glioma: in search of the Rosetta stone |
| Q92355904 | Platelets and their biomimetics for regenerative medicine and cancer therapies |
| Q47667015 | Recent Progress in Near Infrared Light Triggered Photodynamic Therapy. |
| Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
| Q47133839 | Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors |
| Q38521752 | Stem cell in alternative treatments for brain tumors: potential for gene delivery |
| Q38245163 | Stem cell-based therapies for cancer treatment: separating hope from hype |
| Q55400539 | Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives. |
| Q47142453 | Stem cells in cancer therapy: opportunities and challenges |
| Q34938608 | Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy |
| Q61797466 | Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency |
| Q37708056 | Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy |
| Q35105127 | Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules. |
| Q27693205 | The potential of polymeric micelles in the context of glioblastoma therapy |
| Q37338427 | Therapeutic nanomedicine for brain cancer |
| Q57367727 | Vectorization of ultrasound-responsive nanoparticles in placental mesenchymal stem cells for cancer therapy |
Search more.